Non-Invasive Biomarkers for Earlier Detection of Pancreatic Cancer—A Comprehensive Review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-Invasive Biomarkers for Earlier Detection of Pancreatic Cancer—A Comprehensive Review
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 11, Pages 2722
Publisher
MDPI AG
Online
2021-06-01
DOI
10.3390/cancers13112722
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PDAC-ANN: an artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression
- (2020) Palloma Porto Almeida et al. BMC CANCER
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Early detection of pancreatic cancer
- (2020) Stephen P Pereira et al. Lancet Gastroenterology & Hepatology
- A Multianalyte Panel Consisting of Extracellular Vesicle miRNAs and mRNAs, cfDNA, and CA19-9 Shows Utility for Diagnosis and Staging of Pancreatic Ductal Adenocarcinoma
- (2020) Zijian Yang et al. CLINICAL CANCER RESEARCH
- Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
- (2020) M.C. Liu et al. ANNALS OF ONCOLOGY
- Utilisation of artificial intelligence for the development of an EUS-convolutional neural network model trained to enhance the diagnosis of autoimmune pancreatitis
- (2020) Neil B Marya et al. GUT
- A roadmap for the early detection and diagnosis of cancer
- (2020) David Crosby et al. LANCET ONCOLOGY
- Untargeted longitudinal analysis of a wellness cohort identifies markers of metastatic cancer years prior to diagnosis
- (2020) Andrew T. Magis et al. Scientific Reports
- A Transcriptomics-Based Meta-Analysis Combined With Machine Learning Identifies a Secretory Biomarker Panel for Diagnosis of Pancreatic Adenocarcinoma
- (2020) Indu Khatri et al. Frontiers in Genetics
- A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case–control study
- (2020) Silvana Debernardi et al. PLOS MEDICINE
- Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancreatic cancer
- (2019) Tao Wei et al. CANCER LETTERS
- Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood
- (2019) Maryam A. L. Eissa et al. Clinical Epigenetics
- Next-Generation Sequencing in Pancreatic Cancer
- (2019) Gong-Qing Shen et al. PANCREAS
- Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study
- (2019) Sam Sollie et al. BMC CANCER
- Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma
- (2019) Shulin Yu et al. GUT
- Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients
- (2019) Oleg Blyuss et al. BRITISH JOURNAL OF CANCER
- Circulating extracellular vesicle‐encapsulated HULC is a potential biomarker for human pancreatic cancer
- (2019) Kenji Takahashi et al. CANCER SCIENCE
- Peripheral blood monocyte counts are elevated in the pre-diagnostic phase of pancreatic cancer: A population based study
- (2019) Jaime de la Fuente et al. PANCREATOLOGY
- Integrated Analysis of Exosomal Protein Biomarkers on Alternating Current Electrokinetic Chips Enables Rapid Detection of Pancreatic Cancer in Patient Blood
- (2018) Jean M. Lewis et al. ACS Nano
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer
- (2018) Dong Dong et al. CANCER SCIENCE
- Noninvasive Diagnosis of Pancreatic Cancer Through Detection of Volatile Organic Compounds in Urine
- (2018) Ramesh P. Arasaradnam et al. GASTROENTEROLOGY
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Diagnosis: CancerSEEK and destroy — a blood test for early cancer detection
- (2018) David Killock Nature Reviews Clinical Oncology
- Validation of Biomarkers for Early Detection of Pancreatic Cancer
- (2018) Matthew R. Young et al. PANCREAS
- Detection and localization of surgically resectable cancers with a multi-analyte blood test
- (2018) Joshua D. Cohen et al. SCIENCE
- Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden
- (2018) Adam E. Frampton et al. Oncotarget
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Protein Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: Progress and Challenges
- (2018) Alex Root et al. Cancers
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma
- (2018) Max Michael Traeger et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer
- (2018) Linda D. Mellby et al. JOURNAL OF CLINICAL ONCOLOGY
- The Use of Biomarkers in Early Diagnostics of Pancreatic Cancer
- (2018) Lumir Kunovsky et al. Canadian Journal of Gastroenterology and Hepatology
- A review of lifestyle, metabolic risk factors and blood‐based biomarkers for early diagnosis of pancreatic ductal adenocarcinoma
- (2018) Yuanjie Pang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma
- (2018) Cong-ya Zhou et al. Cancer Medicine
- Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations
- (2017) Lei Huang et al. GUT
- Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk
- (2017) Yong Cui et al. INTERNATIONAL JOURNAL OF CANCER
- A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer
- (2017) Seetharaman Balasenthil et al. JNCI-Journal of the National Cancer Institute
- Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy
- (2017) Katherine S. Yang et al. Science Translational Medicine
- Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers
- (2017) Jungsun Kim et al. Science Translational Medicine
- HYAL2 methylation in peripheral blood as a potential marker for the detection of pancreatic cancer: a case control study
- (2017) Sarah Schott et al. Oncotarget
- Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel
- (2017) Jiyoung Park et al. Oncotarget
- A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer
- (2017) Seetharaman Balasenthil et al. JNCI-Journal of the National Cancer Institute
- A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study
- (2016) Sukhwinder Kaur et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer
- (2016) J S Ankeny et al. BRITISH JOURNAL OF CANCER
- Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags
- (2016) Kazuyuki Sogawa et al. BRITISH JOURNAL OF CANCER
- Dysbindin as a novel biomarker for pancreatic ductal adenocarcinoma identified by proteomic profiling
- (2016) Xin Guo et al. INTERNATIONAL JOURNAL OF CANCER
- Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer
- (2016) Neveen Abd El Moneim Hussein et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer
- (2016) Michela Capello et al. JNCI-Journal of the National Cancer Institute
- STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration
- (2016) Jérémie F Cohen et al. BMJ Open
- Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma
- (2016) Stine Dam Henriksen et al. Clinical Epigenetics
- Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer
- (2016) Michela Capello et al. JNCI-Journal of the National Cancer Institute
- Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics
- (2016) Toshihiro Yoneyama et al. PLoS One
- Cross-Species Antibody Microarray Interrogation Identifies a 3-Protein Panel of Plasma Biomarkers for Early Diagnosis of Pancreas Cancer
- (2015) J. E. Mirus et al. CLINICAL CANCER RESEARCH
- Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus
- (2015) C. Jenkinson et al. CLINICAL CANCER RESEARCH
- Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma
- (2015) T. P. Radon et al. CLINICAL CANCER RESEARCH
- Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
- (2015) Sonia A. Melo et al. NATURE
- Current status and progress of pancreatic cancer in China
- (2015) Quan-Jun Lin WORLD JOURNAL OF GASTROENTEROLOGY
- Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer
- (2015) Su-xia Han et al. Oncotarget
- Serum CA19-9 Is Significantly Upregulated up to 2 Years before Diagnosis with Pancreatic Cancer: Implications for Early Disease Detection
- (2014) Darragh P. O'Brien et al. CLINICAL CANCER RESEARCH
- MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer
- (2014) Nicolai A. Schultz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Identification of Human Complement Factor B as a Novel Biomarker Candidate for Pancreatic Ductal Adenocarcinoma
- (2014) Min Jung Lee et al. JOURNAL OF PROTEOME RESEARCH
- Clinical significance of elevated serum soluble CD40 ligand levels as a diagnostic and prognostic tumor marker for pancreatic ductal adenocarcinoma
- (2014) Hye Chung et al. Journal of Translational Medicine
- Prediagnostic Serum Biomarkers as Early Detection Tools for Pancreatic Cancer in a Large Prospective Cohort Study
- (2014) Brian M. Nolen et al. PLoS One
- Plasma interleukin-11 (IL-11) levels have diagnostic and prognostic roles in patients with pancreatic cancer
- (2014) Chuanli Ren et al. TUMOR BIOLOGY
- Pancreatic ductal adenocarcinoma: Risk factors, screening, and early detection
- (2014) Andrew E Becker WORLD JOURNAL OF GASTROENTEROLOGY
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
- (2013) Penny F. Whiting ANNALS OF INTERNAL MEDICINE
- A Novel Serum Metabolomics-Based Diagnostic Approach to Pancreatic Cancer
- (2013) T. Kobayashi et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease Controls
- (2013) A. Li et al. CLINICAL CANCER RESEARCH
- Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature
- (2013) Ola Ghatnekar et al. INTERNATIONAL JOURNAL OF CANCER
- Development of serum parameters panels for the early detection of pancreatic cancer
- (2013) Pengjun Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models
- (2013) Michela Capello et al. Journal of Hematology & Oncology
- Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma
- (2013) CHENYAN ZHAO et al. ONCOLOGY REPORTS
- The Pitfalls of CA19-9
- (2012) Rita Passerini et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- PAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinoma
- (2012) David V. Gold et al. CANCER
- Strategies for discovering novel pancreatic cancer biomarkers
- (2012) Alison Chan et al. Journal of Proteomics
- Serum CA19-9, cathepsin D, and matrix metalloproteinase-7 as a diagnostic panel for pancreatic ductal adenocarcinoma
- (2012) Hyung-Doo Park et al. PROTEOMICS
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
- (2012) Douglas G. Altman et al. PLOS MEDICINE
- Biospecimen reporting for improved study quality (BRISQ)
- (2011) Helen M. Moore et al. CANCER CYTOPATHOLOGY
- Serum Biomarker Panels for the Detection of Pancreatic Cancer
- (2011) R. E. Brand et al. CLINICAL CANCER RESEARCH
- Detection of Early-Stage Pancreatic Adenocarcinoma
- (2010) D. V. Gold et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Soluble iC3b as an Early Marker for Pancreatic Adenocarcinoma Is Superior to CA19.9 and Radiology
- (2010) Angela Märten et al. JOURNAL OF IMMUNOTHERAPY
- Distant metastasis occurs late during the genetic evolution of pancreatic cancer
- (2010) Shinichi Yachida et al. NATURE
- Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report
- (2009) M. J. Duffy et al. ANNALS OF ONCOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Comparison of three immunoassays for CA 19-9
- (2008) Kristina Hotakainen et al. CLINICA CHIMICA ACTA
- The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline
- (2008) Amanda G. Paulovich et al. Proteomics Clinical Applications
- Biology and management of pancreatic cancer
- (2007) P Ghaneh et al. POSTGRADUATE MEDICAL JOURNAL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started